Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24.
Bar, Jair
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24. [electronic resource] - Clinical lung cancer Nov 2015 - e189-201 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1938-0690
10.1016/j.cllc.2015.05.002 doi
Aldosterone--blood
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Pharmacological--blood
Canada
Carcinoma, Non-Small-Cell Lung--diagnosis
Female
Humans
Lung Neoplasms--diagnosis
Male
Middle Aged
Peptidyl-Dipeptidase A--blood
Predictive Value of Tests
Prognosis
Quinazolines--administration & dosage
Survival Analysis
Treatment Outcome
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24. [electronic resource] - Clinical lung cancer Nov 2015 - e189-201 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1938-0690
10.1016/j.cllc.2015.05.002 doi
Aldosterone--blood
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Pharmacological--blood
Canada
Carcinoma, Non-Small-Cell Lung--diagnosis
Female
Humans
Lung Neoplasms--diagnosis
Male
Middle Aged
Peptidyl-Dipeptidase A--blood
Predictive Value of Tests
Prognosis
Quinazolines--administration & dosage
Survival Analysis
Treatment Outcome